Tradr 2X Long CEG Daily ETF

31.09

+0.97003.22%

Volume:13.04K

Turnover:405.51K

Market Cap:30.57B

PE:- -

High:31.27

Open:30.28

Low:30.28

Close:30.12

Loading ...

Overview Company News Filings

Concept

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Cambridge Epigenetix Names Peter Fromen as Chief Executive Officer

GlobeNewswire

·

14 Jun 2022

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/CEGX"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CEGX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CEGX\",,,,,undefined,":{"symbol":"CEGX","market":"US","secType":"STK","nameCN":"Tradr 2X Long CEG Daily ETF","latestPrice":31.09,"timestamp":1753972069668,"preClose":30.12,"halted":0,"volume":13042,"delay":0,"floatShares":60000000,"shares":983376477,"eps":0,"marketStatus":"Trading","change":0.97,"latestTime":"07-31 10:33:18 EDT","open":30.28,"high":31.27,"low":30.28,"amount":405509.141436,"amplitude":0.032869,"askPrice":31.49,"askSize":400,"bidPrice":31.19,"bidSize":400,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1753992000000},"marketStatusCode":2,"adr":0,"exchange":"CBOE","adjPreClose":30.12,"aum":1000000,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":31,"preClose":30.12,"latestTime":"08:54 EDT","volume":1839,"amount":56890.607019,"timestamp":1753966492080},"postHourTrading":{"tag":"盘后","latestPrice":31.46,"preClose":30.12,"latestTime":"19:38 EDT","volume":6715,"amount":208168.99,"timestamp":1753918737148},"volumeRatio":3.330066,"impliedVol":0.7111,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CEGX\",,,,,undefined,":{"symbol":"CEGX","floatShares":60000000,"roa":"--","roe":"--","lyrEps":-0.248339,"volumeRatio":3.330066,"shares":983376477,"dividePrice":0,"high":31.27,"amplitude":0.032869,"preClose":30.12,"low":30.28,"week52Low":23.13,"pbRate":"--","week52High":31.27,"institutionHeld":0,"latestPrice":31.09,"eps":0,"divideRate":0,"volume":13042,"delay":0,"ttmEps":0,"open":30.28,"prevYearClose":24.68,"prevWeekClose":27.01,"prevMonthClose":24.68,"prevQuarterClose":24.68,"fiveDayClose":26.1808},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/CEGX\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CEGX\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2243670005","title":"Cambridge Epigenetix Names Peter Fromen as Chief Executive Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2243670005","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2243670005?lang=en_us&edition=fundamental","pubTime":"2022-06-14 21:00","pubTimestamp":1655211600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/5qoMZQcaza3.lm48KdFl9g--~B/aD0xNTc3O3c9MTU3NzthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/uu/api/res/1.2/lKwFkwoMk6rfRlmuj5HE0Q--~B/aD0xNTc3O3c9MTU3NzthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/662f50d19de6d1604df39df5abd648fa","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/5qoMZQcaza3.lm48KdFl9g--~B/aD0xNTc3O3c9MTU3NzthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/uu/api/res/1.2/lKwFkwoMk6rfRlmuj5HE0Q--~B/aD0xNTc3O3c9MTU3NzthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/662f50d19de6d1604df39df5abd648fa"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cambridge-epigenetix-names-peter-fromen-130000683.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NHS","BK4121","BK4009","PACB","CEGX","CCO"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CEGX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CEGX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CEGX\",market:\"US\",delay:false,,,undefined,":{}}}